•  
  •  
 

The Thai Journal of Pharmaceutical Sciences

Abstract

Medication error (ME) can occur throughout the patient care process. Medication reconciliation (MR) is widely accepted as a tool to prevent the occurrence of ME by 63–66%. Currently, a computer-based process has been used for MR, making it convenient and quick to operate more than usual recording. In 2019, it was used for the 1st time in Ta Phraya Hospital but it has not been evaluated. Therefore, the researcher is interested in analyzing net-benefit in inpatients with chronic non-communicable diseases by comparing patients receiving and not receiving MR and study MEs. This retrospective study collected data in the admission and discharge process by dividing patients into two groups of 563 patients in each group. MR group consisted of patients receiving MR process, collected data from October 1, 2019, to September 30, 2020, and No MR group consisted of patients not receiving MR process, collected data from October 1, 2018, to September 30, 2019. The costs and the cost savings were collected and analyzed using STATA Version 14.0. One-way sensitivity analysis was conducted in this study. The result found that most of the patients in both groups were ≥60 years old, female, and eligible for universal health insurance. General data showed no significant difference between groups. All 120 MEs in this study, included 67 (6.0%) and 53 (4.7%) MEs in MR and No MR groups, respectively. The most common ME in both groups was omission error. Net benefit and benefit-to-cost ratio (B/C ratio) were 325.7 and 5.9, respectively. One-way sensitivity analysis showed a positive net benefit and B/C ratio. This study suggests that implementing MR in inpatient care can be a cost savings strategy compared with usual care.

Download

Share

COinS